-
Published02/02/2012
-
Deadline13/03/2012
-
Opening of tenders13/03/2012
-
Awarded11/04/2012
-
Today07/08/2026
Utilities
- indicates text translated automatically in your browsing language
PL-Rzeszów: heparin
The subject-matter of the contract is the supply of small-molecular heparins and medicines: Pazopanib, Levofloxacinum, adalimumab and Dacarbazine, listed in the Parts for the Fryderyk Chopin Provincial Specialist Hospital in Rzeszów, including:
— Fine molecule heparin: Nadroparinum calcium – Part No 1,
— Fine molecule heparin: Enoxaparinum sodium – Part No 2,
— Fine molecule heparin: Dalteparin sodium – Part No 3,
— Pazopanib tabl. Part No 4,
— Levofloxacinum 500 mg/100ml r-r for infusion – Part No 5,
— Adalimumab 40 mg/0.8ml – Part No 6,
— Dacarbazine 200 mg – Part No 7,
— Dacarbazine 100 mg – Part No 8.
A description of the contracting authority’s needs, including the requirements and indicative quantities of supplies during the period covered by the contract, is set out in Annex 1 – Price forms – bid forms which form an integral part of the ToR.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.